Immunological differences between heart- and kidney-transplanted children: a cross-sectional study.

Area of Science:

• Pediatric Immunology
• Transplantation Medicine
• Oncology

Background:

• Post-transplantation lymphoproliferative disorder (PTLD) is a life-threatening complication following pediatric heart transplantation.
• Immune system dysfunction is central to lymphoma development, particularly after organ transplantation.
• Understanding thymus function is crucial for managing immunosuppressive therapy and PTLD risk.

Purpose of the Study:

• To investigate the impact of thymus function on immunosuppressive treatment outcomes in pediatric organ transplant recipients.
• To compare immune profiles of heart-transplanted children with kidney-transplanted children and healthy controls.
• To explore the relationship between thymic function markers and PTLD development.

Main Methods:

• A prospective case-control study involving 36 heart-transplanted, 34 kidney-transplanted, and 33 healthy children.
• Flow cytometry was used to analyze T- and B-lymphocyte subtypes and monocytes.
• Quantitative polymerase chain reaction assessed T-cell receptor excision circles (TRECs) as a marker of thymic function.

Main Results:

• Heart-transplanted children demonstrated significantly reduced thymic function, evidenced by low TRECs and decreased naive T cells.
• Immune activation against the allograft was observed in heart-transplant recipients.
• Kidney-transplanted children, despite similar immunosuppression, presented with an activated T-lymphocyte compartment.

Conclusions:

• Pediatric heart transplantation is associated with impaired thymic output and immune activation.
• These immune alterations may increase the susceptibility to PTLD in pediatric heart transplant recipients.
• Further research is needed to optimize immunosuppression and mitigate PTLD risks.